NuVasive Inc. (NUVA)

52.23
0.79 1.50
NASDAQ : Health Technology
Prev Close 53.02
Open 53.18
Day Low/High 51.56 / 53.30
52 Wk Low/High 44.62 / 81.68
Volume 521.87K
Avg Volume 787.50K
Exchange NASDAQ
Shares Outstanding 51.26M
Market Cap 2.71B
EPS 1.60
P/E Ratio 35.26
Div & Yield N.A. (N.A)

Latest News

NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches

NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches

ALIF Access aligns with Company's focus on single-position surgery

Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction

Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction

Results of Porous PEEK™ impaction durability study now available in The Spine Journal

First Week of May 18th Options Trading For Nuvasive Inc (NUVA)

First Week of May 18th Options Trading For Nuvasive Inc (NUVA)

Investors in Nuvasive Inc saw new options begin trading this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NUVA options chain for the new May 18th contracts and identified one put and one call contract of particular interest.

NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services

NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services

SpineTRACK allows surgeons to meet quality tracking requirements for Medicare incentives

NuVasive Extends First-Of-Its-Kind Porous PEEK Interbody To TLIF And PLIF Procedures

NuVasive Extends First-Of-Its-Kind Porous PEEK Interbody To TLIF And PLIF Procedures

Company also receives expanded FDA 510(k) clearance for COALESCE™ Thoracolumbar Interbody Fusion Device and COHERE® Cervical Interbody Fusion Device for multi-level cases from C2-T1

NuVasive Comments On Expected Impact Of U.S. Tax Reform

NuVasive Comments On Expected Impact Of U.S. Tax Reform

Company expects savings to fuel innovation and growth in spine surgery solutions

NuVasive To Acquire SafePassage

NuVasive To Acquire SafePassage

- Expands the Company's Position as the Leading Provider of Intraoperative Neurophysiological Monitoring Services with Complementary Geographic Footprint

NUVA: Insiders vs. Shorts

NUVA: Insiders vs. Shorts

The most recent short interest data was recently released for the 11/30/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 10.32 "days to cover" versus the median component at 5.11. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Which Way Are These Stocks Going?

Which Way Are These Stocks Going?

Finding bullish and bearish reversals in the market.

5 Stocks That Look Good Short

5 Stocks That Look Good Short

Among them are a motorcycle maker and a seller of undergarments.

A Motorcycle Maker, an Undergarment Seller and Other Stocks That Look Good Short

VIRT, HOG, HBI, NUVA and ATHN all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: FNWB, GS, LIVE, RMBS Downgrades: BOJA, MJCO, NUVA, WYNN Initiations: SBOW Read on to get TheStreet Quant Ratings' detailed report:

Arons & Arons, LLC. Announces Investigation On Behalf Of NuVasive, Inc. Investors

Arons & Arons, LLC. Announces Investigation On Behalf Of NuVasive, Inc. Investors

The Law Firm of Arons & Arons, LLC. has initiated an investigation of NuVasive, Inc.

NUVA: Insiders Vs. Shorts

NUVA: Insiders Vs. Shorts

The most recent short interest data was recently released for the 08/31/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 8.81 "days to cover" versus the median component at 6.19. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

Biotech Movers: Cesca Up Strong After Securing CAR-T Cell Patent

And a management shakeup helps push down NuVasive.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AIG, ALSK, GNE, GUID, HTH, LPI, NUVA, PIRS, QRVO, S, TTMI Downgrades: ARRS, BPMC, CONE, CRAY, EFII, GIL, GKOS, HYH, SUM Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

NUVA: Insiders vs. Shorts

The most recent short interest data was recently released for the 04/13/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 10.25 "days to cover" versus the median component at 5.14. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Insider Bets Paying Off At NUVA As New 52-Week High Reached

In trading on Monday, shares of Nuvasive Inc touched a new 52-week high of $77.88/share. That's a 56.17% rise, or $28.01 per share from the 52-week low of $49.87 set back on 04/22/2016.

Masimo's Stock Is a Great Buy Right Now

Masimo's Stock Is a Great Buy Right Now

This patient-monitoring device-maker has plenty of room for growth.

NUVA: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/13/2017 settlement date, and Nuvasive Inc is one of the most shorted stocks of the Russell 3000, based on 6.67 "days to cover" versus the median component at 5.04. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Are People Finally Noticing?

Recognition of the market's inertia seems to be growing.

TheStreet Quant Rating: C+ (Hold)